Eiji Sunami, Kentaro Yamazaki, Manabu Shiozawa, Dai Manaka, Masahito Kotaka, Yasuhiro Sakamoto, Akio Shiomi, Yudai Shinohara, Yoshinori Munemoto, Toshiki Rikiyama, Mutsumi Fukunaga, Takashi Ueki, Kohei Shitara, Jun Yamada, Nobuyuki Tanida, Toshihiro Misumi, Atsushi Ohtsu, Yoshihiko Maehara, Takayuki Yoshino. "Seven-year efficacy and safety in a randomized phase III trial investigating duration of adjuvant oxaliplatin-based therapy (3 vs. 6 months) for patients with high-risk stage II colon cancer: ACHIEVE-2 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.169